LumaCina - Bridgewest Perth Pharma
Martin Werschlan has extensive experience in finance, procurement, and digital operations. Martin currently serves as SVP at LumaCina International - Bridgewest Perth Pharma, and previously held positions at NovaCina and Bridgewest Group. Martin has also been involved with organizations such as ACHA-Americas Continental Health Alliance and dHealth Foundation. With a background in finance and accounting, Martin has worked in various roles including General Manager at Roche, Finance Area Head for LATAM & Africa, and Finance Manager in multiple countries. Martin holds a degree in Finance & Accounting from the University of St. Gallen.
This person is not in any teams
LumaCina - Bridgewest Perth Pharma
Empowering Health Worldwide: Welcome to Lumacina, Your Global Hub for Cutting-Edge Sterile Injectable Solutions! As proud distributors of a dynamic portfolio we ensure top-notch quality. Our futuristic R&D is propelling a wave of innovation, set to revolutionize regulated and semi-regulated markets across the globe. From multi-dose vials to blow-fill-seal presentations and cytotoxic products, we're the pioneers of diverse dosage forms. Bridgewest Group Fueling Innovation: Lumacina, a Luminary in Bridgewest Perth Pharma, a Proud Entity of Bridgewest Group. Unleashing Potential with NovaCina and LumaCina, We're Transforming the Future of Healthcare."